Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
NCT00782340Phase 3Completed
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Sep 2008
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Neurogenic Orthostatic Hypotension (nOH) comparing Droxidopa with Placebo (2 arms). Primary endpoint: Orthostatic Hypotension Questionnaire Score at 7 days. Started Sep 2008; status: completed.
02
Drugs
droxidopa
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT00782340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782340.